Table 1.
Day 0 | Day 14 | Day 28 | ||||
---|---|---|---|---|---|---|
Cell number | Cell number | Fold increase | Cell number | Fold increase | ||
Adult NKT | Exp. 1 | 16 | 2,200 | 140 | 7,700 | 480 |
Exp. 2 | 16 | 500 | 31 | NA | NA | |
Exp. 3 | 1.5 | 78 | 52 | 1,210 | 810 | |
Neonatal NKT | Exp. 1 | 1.5 | 6,200 | 4,100 | NA | NA |
Exp. 2 | 0.4 | 3,030 | 7,600 | 27,000 | 67,500 | |
Exp. 3 | 0.3 | 920 | 3,100 | 1,910 | 6,400 |
Vα24+Vβ11+ NKT cells were purified by cell sorting and expanded with plate-bound anti-CD3 and soluble anti-CD28 mAbs in the presence of PHA, IL-2, and IL-7 for two rounds (14 d each). Cell numbers were counted on days 0, 14, and 28, and are shown at ×10−3. Fold increase: compared to the starting cell numbers.
Exp., experiment.
NA, not available.